University of Pennsylvania Abramson Cancer Center — Philadelphia, Pennsylvania

University of Pennsylvania Abramson Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Pennsylvania Abramson Cancer Center has participated in 43 clinical trials with 13 currently active.

Therapeutic areas: Malignant Pleural Mesothelioma, Advanced Malignancies, Non-small Cell Lung Cancer, Metastatic Pancreatic Cancer.

Sponsors: Ferring Ventures Limited, Mirati Therapeutics Inc., Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Pennsylvania Abramson Cancer Center?

University of Pennsylvania Abramson Cancer Center has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Pennsylvania Abramson Cancer Center conducted?

University of Pennsylvania Abramson Cancer Center has 43 clinical trials on record, with 13 currently active. Their work covers Malignant Pleural Mesothelioma, Advanced Malignancies, Non-small Cell Lung Cancer, Metastatic Pancreatic Cancer.

Is University of Pennsylvania Abramson Cancer Center accredited by Crixeo Health?

Yes — University of Pennsylvania Abramson Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about University of Pennsylvania Abramson Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.